VT
Venkatacharyulu Tarigoppala
About Venkatacharyulu Tarigoppala
Data last updated:
Venkatacharyulu Tarigoppala is an Additional Director at Herbogenix Private Limited (since 2025) and Director at Cynergy Club Health Private Limited (since 2026). The companies operate in Healthcare. The largest current company by reported revenue is Herbogenix Private Limited at ₹1.65 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Herbogenix Private Limited U74999AP2020PTC114107 | Additional Director | 26 Aug 2025 | 2020 | ₹1.65 Cr (FY 2023) | Active |
 Cynergy Club Health Private Limited U47912AP2026PTC126819 | Director | 09 Jul 2026 | 2026 | Active |
Board colleagues of Venkatacharyulu Tarigoppala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sobha Rani Tarigoppala | 09597652 | Herbogenix Private Limited | Additional Director |
| Sarvadevullu Amara | 10866458 | Cynergy Club Health Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkatacharyulu Tarigoppala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkatacharyulu Tarigoppala
Venkatacharyulu Tarigoppala currently holds 2 directorships: Herbogenix Private Limited (Additional Director, since 26 Aug 2025, revenue ₹1.65 Cr (FY 2023)); Cynergy Club Health Private Limited (Director, since 09 Jul 2026).
Venkatacharyulu Tarigoppala was first appointed on 26 Aug 2025 as Additional Director at Herbogenix Private Limited. The most recent appointment on record is 09 Jul 2026 at Cynergy Club Health Private Limited.
The current boards of Venkatacharyulu Tarigoppala's companies include Sobha Rani Tarigoppala (Herbogenix Private Limited), Sarvadevullu Amara (Cynergy Club Health Private Limited).